Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001453687-24-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-02 | RNAC | BARABE TIMOTHY C | Dir | A - Grant | $0.00 | +178.0K | 428.0K | +71% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | BARABE TIMOTHY C | Dir | A - Grant | $0.00 | +228.0K | 228.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | A | A | 178,000 | $0.00 | 428,013 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | A | A | 228,000 | $0.00 | 228,000 | D | $0.66 · — to 2034-01-01 | 228,000 Common Stock | (F2) This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027. |